VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
The event will be attended by 35,000+ industry professionals
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Miels will formally assume the role on January 1, 2026
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
